Elemental impurities in pharmaceutical products represent a critical area of research, driven by heightened regulatory scrutiny and a growing imperative to ensure patient safety. Such impurities, ...

Researchers highlight the significance of plant-based alternatives for disease treatment, as well as of advanced diagnostic tools through the development of metabolomics. IBD is a common chronic ...

The use of acidic MPAs (pH 2–4) is the default in pharmaceutical testing because they suppress silanol ionization (from Si-OH to Si-O -) and improve peak shape for basic drugs. However, highly ...

Current Pharmaceutical Analysis (CPA) is a distinguished journal in the field of pharmaceutical and biomedical analysis. Published by Far Publishing Company, CPA provides a platform for researchers to ...

Our successful June two-day online event that focused on challenges and trends in Pharma Analysis & QC is now available on demand. With the pharma value chain rapidly evolving – and with over a year ...

Elemental analysis plays a crucial role in the pharmaceutical industry, allowing scientists to understand a material or compound’s elemental composition. It also provides key information on any ...

In a competitive industry, PerkinElmer increases productivity in pharmaceutical laboratories and improves sample analysis throughput by completing two analytical techniques at the same time. The Pyris ...

DUBLIN--(BUSINESS WIRE)--The "Pharmaceutical Regulatory Affairs Market Size, Share & Trends Analysis Report By Service Provider, By Service, By Category, By Indication, By Development Stage, By ...

Gas analysis is a crucial aspect of pharmaceutical quality control, which plays a significant role in ensuring the safety and efficacy of drugs. This article discusses the role of gas analysis in ...

When it comes to bringing an experimental drug to market and selling it, Novo Nordisk, the maker of the weight loss drug Wegovy, is tops, according to a new analysis. But if you want to invent lots of ...

Substantial reductions in rate and risk of exacerbations support potential of ensifentrine, an investigational, novel, selective, dual inhibitor of PDE3 and PDE4 LONDON and RALEIGH, N.C., Sept. 06, ...